Krsnaa Diagnostics Publishes Audited Financial Results for Q4 FY26 in Newspapers
Krsnaa Diagnostics Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The advertisements appeared in the Financial Express and Loksatta on May 27, 2026.
This is a standard regulatory filing and does not contain new material information that would significantly impact the company's stock price or operations.
The announcement is a routine disclosure of financial results publication in newspapers, providing no new financial or operational information.
Krsnaa Diagnostics Limited has published newspaper advertisements pertaining to the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
The advertisements were published on May 27, 2026, in two newspapers: the Financial Express (English) and Loksatta (Marathi).
This information is also being hosted on the company's website at www.krsnaadiagnostics.com/investors, in compliance with Regulation 47 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.